| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PI | Common Stock | Options Exercise | $257,800 | +10,000 | +46% | $25.78 | 31,750 | 15 Feb 2024 | Direct | |
| transaction | PI | Common Stock | Sale | $1,062,289 | -10,000 | -31% | $106.23 | 21,750 | 15 Feb 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PI | Stock Option (right to buy) | Options Exercise | $0 | -10,000 | -100% | $0.000000* | 0 | 15 Feb 2024 | Common Stock | 10,000 | $25.78 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.62 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| F2 | The option was approved on September 18, 2020 by the Compensation Committee of the Issuer's Board of Directors in connection with certain consulting services being provided by the Reporting Person. The Option fully vested on October 21, 2022. |